A MRNA1073 single-dose vaccine targeting corona and influenza

Follow - up - INA 

The company of "Moderna" announced on Wednesday, the development of a single - dose vaccine against combines enhanced "Covid -19" dose and the other against the flu.

The new vaccine, called MRNA1073, will be a combination of the company's anti-coronavirus vaccine, with the influenza vaccine that the company is also developing.

"We announce the first step," Moderna CEO Stephan Bancel said in a statement. In our new respiratory vaccine program with the development of a single-dose vaccine that combines a booster dose against corona and a booster against influenza.".

There are currently no details on when clinical trials will begin or when the vaccine will be available to the general public."
On the other hand, the Russian Minister of Health, Mikhail Murashko, announced in a press conference, the end of trials for a single-dose anti-Corona and influenza vaccine.

He added, "We are currently completing the research on the joint use of the two anti-influenza and coronavirus vaccines at the same time.

 Murashko suggested "dissemination of information in the near future.".

American experts had warned of a severe flu season this year. "